Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages.

doi:10.18632/oncotarget.16660

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages.

Oncotarget - 6 Jun 2017

Huang Wei, Song Juan, Jia Xiao-Wei, Chen Yin-Xue, Shi Jia, Jiang Xun

Abstract excerpt

BACKGROUND: The association of interleukin-10 rs1800896 polymorphism with head and neck cancer risk and its clinical stages has been investigated by many published studies, but the results remain inconsistent. Therefore, we conducted this meta-analysis for further investigation. RESULTS: Six case-control studies involving 1,781 head and neck cancer patients and 1,978 controls were yielded. The results indicated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to China

Share to Genetic Association Studies

Share to Germany

Share to Greece

Share to Head and Neck Neoplasms

Share to Interleukin-10

Share to Risk

Source

Open in PubMed Open full text

Identifiers

PMID: 28410223
DOI: 10.18632/oncotarget.16660
PMCID: PMC5514904

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages.PMID 28410223Read ↗

Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis.Semantic proximity Read ↗

Common Polymorphisms of Interleukin-10 (-1082A/G, -592A/C, and -819C/T) in Oral Cancers: An Updated Meta-Analysis.Semantic proximity Read ↗

Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.Semantic proximity Read ↗

Functional polymorphisms in the IL-10 gene with susceptibility to esophageal, nasopharyngeal, and oral cancers.Semantic proximity Read ↗

The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.Semantic proximity Read ↗

Associations between genetic polymorphisms in interleukin-10 and hematological oncology: evidence from a meta-analysis.Semantic proximity Read ↗

Cox-2 and IL-10 polymorphisms and association with squamous cell carcinoma of the head and neck in a Korean sample.Semantic proximity Read ↗

Role of Interleukin-10 Promoter Polymorphisms in Oral Cancer Susceptibility: A Meta-Analysis.Semantic proximity Read ↗

Impact of interleukin-18 polymorphisms -607A/C and -137G/C on oral cancer occurrence and clinical progression.Semantic proximity Read ↗

The association between rs1800872 polymorphism in interleukin-10 and risk of cervical cancer: A meta-analysis.Semantic proximity Read ↗

The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Quantitative assessment of the association between interleukin-10 promoter gene polymorphisms and nasopharyngeal carcinoma susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.